Intravenous Oxytocin Has no Effect on Ad Libitum Food Intake or Postprandial Plasma Glucose Concentrations in Individuals With Obesity: A Randomised, Placebo-Controlled, Double-Blind, Crossover Study
Abstract
Introduction: Oxytocin is expressed throughout the small intestine, suggesting a role for oxytocin in postprandial metabolism. Accordingly, single-dose intranasal oxytocin reduces food intake and improves glucose tolerance. We investigated the effects of a continuous intravenous oxytocin infusion on ad libitum food intake, appetite sensations, and postprandial metabolism.
Methods: In a randomised, placebo-controlled, double-blind, crossover study, overnight fasted participants with obesity underwent two 4.5-hour intravenous infusions of oxytocin (0.2 international units/min) and placebo (saline), respectively, on separate days interposed by a wash-out period of a minimum of seven days. After 60 min of infusion, participants ingested a standardised liquid mixed meal containing 1.5 g paracetamol (for evaluation of gastric emptying). Appetite sensations were assessed by visual analogue scales, and concentrations of plasma glucose as well as glucose and appetite-regulating hormones were measured. After four hours, food intake (primary endpoint) was assessed by an ad libitum meal test.
Results: Twenty-four individuals (12 women, median age 41.5 (interquartile range (IQR) 28.5;55.3) years, body mass index 36.2 (32.1;37.6) kg/m2, mean glycated haemoglobin 34 ± standard deviation (SD) 3.5 mmol/mol) completed the study. Ad libitum food intake was similar between oxytocin and saline infusions (mean 714 ± SD 382 vs. 707 ± 385 kcal). Compared with placebo, oxytocin did not affect…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 12 participants or records.
Read the paper
Related studies
- Effect of dexamethasone as an analgesic adjuvant to multimodal pain treatment after total knee arthroplasty: randomised clinical trial
- Effect of a Postoperative Multimodal Opioid-Sparing Protocol vs Standard Opioid Prescribing on Postoperative Opioid Consumption After Knee or Shoulder Arthroscopy: A Randomized Clinical Trial
- Comparison of the Post-Caesarean Analgesic Effect of Adding Dexmedetomidine to Paracetamol and Ketorolac: A Randomized Clinical Trial
- A triple-blind randomized clinical trial of different associations between dexamethasone and non-steroids anti-inflammatories for preemptive action in third molar extractions
- An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients
- Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: Single centre double-blind, randomised controlled clinical trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.